CAR T-cell;Cell Therapy;chimeric antigen receptor;cytokine receptors;toxicities;Solid Tumors

Modular chimeric cytokine receptors improve CAR T–cell therapy for solid tumors

[ad_1] (MEMPHIS, Tenn. – November 30, 2023) Immunotherapy using modified chimeric antigen receptor (CAR) T cells has greatly improved survival…